サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1375910

子宮内膜焼灼術の市場規模、シェア、動向分析レポート：製品別、最終用途別、地域別、セグメント予測、2023年～2030年

Endometrial Ablation Market Size, Share & Trends Analysis Report By Product (Thermal Balloon, Cryoablation, RFA, Hydrothermal Ablation, Microwave Energy), By End-use (Hospitals, Clinics, ASCs), By Region, And Segment Forecasts, 2023 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 120 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.42円
子宮内膜焼灼術の市場規模、シェア、動向分析レポート：製品別、最終用途別、地域別、セグメント予測、2023年～2030年
出版日: 2023年10月11日
発行: Grand View Research
ページ情報: 英文 120 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

子宮内膜アブレーション市場の成長と動向：

Grand View Research, Incの最新レポートによると、世界の子宮内膜アブレーション市場規模は、2023年から2030年にかけてCAGR 5.16％で拡大し、2030年には16億9,000万米ドルに達すると予測されています。

この成長は、婦人科疾患の有病率の高まりと子宮内膜焼灼術に対する社会的認知度の高まりに起因しています。内分泌学会によると、PCOSは生殖年齢の全女性の7％から10％が罹患し、不妊症の最大の原因です。さらに、婦人科がんに対する認識を高めることが重視されるようになり、特に50歳以降の女性における子宮腺筋症の有病率が増加していることは、世界的に子宮内膜切除術にプラスの影響を与えると思われます。

国連ESCAPによれば、2020年には総人口のうち、60歳以上の人口の約53.2％が女性、80歳以上の人口の約61.2％が女性です。このように、高齢女性人口の増加も市場成長に寄与しています。こうした良好な成長環境にもかかわらず、子宮穿孔、高熱、息切れなど、子宮焼灼手術に関連する潜在的な合併症が市場力学を若干阻害する可能性があります。さらに、手術に代わる低侵襲の子宮内膜焼灼術が利用できるようになったため、日帰り手術で子宮内膜をその場で破壊することが可能になっています。この方法はリスクが少なく、技術的にも簡単です。

国際産科婦人科連合（FIGO）によれば、生殖期における異常子宮出血（AUB）は、生殖年齢にある女性の間で約3～30％の発生率で、世界的に大きな影響を及ぼしています。これにより、市場全体の成長が促進されると期待されています。世界の市場関係者は、AUBのような女性関連疾患に関する認識を高めるために、ソーシャルメディアキャンペーンを企画したりウェブサイトを立ち上げたりするなど、さまざまな取り組みを行っています。この戦略により、企業は能力を高め、能力を向上させ、製品ポートフォリオを拡大することができます。例えば、2022年8月、ミネルバ・サージカル社は「Time to Talk」ソーシャルメディアキャンペーンと地域イベントシリーズを開始しました。この取り組みは、AUBに関する世界の認知度向上につながります。この取り組みにより、子宮内膜焼灼装置の消費者層が拡大し、収益創出の原動力となると思われます。

子宮内膜アブレーション市場レポート・ハイライト

  • 2022年には、子宮内膜層除去のためのRFA機器需要の増加により、ラジオ波焼灼療法（RFA）製品セグメントが市場を独占しました。
  • 2022年には、子宮内膜焼灼術を行うのに病院よりもクリニックが好まれるようになったため、クリニックセグメントが市場を独占しました。
  • 北米が2022年に最大のシェアを占めたのは、婦人科疾患の患者数の増加、ヘルスケアインフラの改善、最先端の子宮内膜焼灼装置を提供する業界トップ企業の強固な基盤が背景にあります。
  • 市場プレーヤーは、市場での自社製品のリーチを拡大し、多様な地域での利用可能性を向上させるために様々な戦略を採用しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 子宮内膜アブレーション市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 子宮内膜アブレーション市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 子宮内膜アブレーション市場：製品推定・動向分析

  • 製品市場シェア、2018年と2030年
  • セグメントダッシュボード
  • 製品別の世界の子宮内膜アブレーション市場の見通し
  • 以下の市場規模、予測および動向分析、2023年から2030年まで

第5章 子宮内膜アブレーション市場：最終用途推定・動向分析

  • 最終用途市場シェア、2018年および2030年
  • セグメントダッシュボード
  • 最終用途別の世界の子宮内膜アブレーション市場の見通し
  • 以下の市場規模、予測および動向分析、2023年から2030年まで

第6章 子宮内膜アブレーション市場：地域推定・動向分析

  • 地域市場シェア分析、2018年および2030年
  • 地域市場ダッシュボード
  • 世界の地域市場のスナップショット
  • 2023年から2030年の市場規模と予測トレンド分析：
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • スウェーデン
    • デンマーク
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 会社/競合の分類
    • イノベーター
  • ベンダー情勢
    • List of key distributors and channel partners
    • Key customers
    • Key company market share analysis, 2022
    • Medtronic.
    • The Cooper Companies, Inc.
    • Boston Scientific Corporation
    • Johnson &Johnson Service Inc.
    • Olympus Corporation
    • Richard Wolf GmbH.
    • AngioDynamics.
    • Hologic, Inc.
    • Minerva Surgical, Inc.
図表

List of Tables

  • Table 1 List of regulatory bodies for different countries
  • Table 2 Key companies' product launches
  • Table 3 Key companies' merger and acquisitions
  • Table 4 Key companies' collaboration
  • Table 5 Other strategic initiatives of companies
  • Table 6 North America endometrial ablation market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America endometrial ablation market, by product, 2018 - 2030 (USD Million)
  • Table 8 North America endometrial ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 9 U.S. endometrial ablation market, by product, 2018 - 2030 (USD Million)
  • Table 10 U.S. endometrial ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 11 Canada endometrial ablation market, by product, 2018 - 2030 (USD Million)
  • Table 12 Canada endometrial ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 13 Europe endometrial ablation market, by country, 2018 - 2030 (USD Million)
  • Table 14 Europe endometrial ablation market, by product, 2018 - 2030 (USD Million)
  • Table 15 Europe endometrial ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 16 UK endometrial ablation market, by product, 2018 - 2030 (USD Million)
  • Table 17 UK endometrial ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 18 Germany endometrial ablation market, by product, 2018 - 2030 (USD Million)
  • Table 19 Germany endometrial ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 20 France endometrial ablation market, by product, 2018 - 2030 (USD Million)
  • Table 21 France endometrial ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 22 Italy endometrial ablation market, by product, 2018 - 2030 (USD Million)
  • Table 23 Italy endometrial ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 24 Spain endometrial ablation market, by product, 2018 - 2030 (USD Million)
  • Table 25 Spain endometrial ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 26 Norway endometrial ablation market, by product, 2018 - 2030 (USD Million)
  • Table 27 Norway endometrial ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Sweden endometrial ablation market, by product, 2018 - 2030 (USD Million)
  • Table 29 Sweden endometrial ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 30 Denmark endometrial ablation market, by product, 2018 - 2030 (USD Million)
  • Table 31 Denmark endometrial ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 32 Asia Pacific endometrial ablation market, by country, 2018 - 2030 (USD Million)
  • Table 33 Asia Pacific endometrial ablation market, by product, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific endometrial ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 35 Japan endometrial ablation market, by product, 2018 - 2030 (USD Million)
  • Table 36 Japan endometrial ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 37 China endometrial ablation market, by product, 2018 - 2030 (USD Million)
  • Table 38 China endometrial ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 39 India endometrial ablation market, by product, 2018 - 2030 (USD Million)
  • Table 40 India endometrial ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Australia endometrial ablation market, by product, 2018 - 2030 (USD Million)
  • Table 42 Australia endometrial ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 43 South Korea endometrial ablation market, by product, 2018 - 2030 (USD Million)
  • Table 44 South Korea endometrial ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 45 Thailand endometrial ablation market, by product, 2018 - 2030 (USD Million)
  • Table 46 Thailand endometrial ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 47 Latin America endometrial ablation market, by country, 2018 - 2030 (USD Million)
  • Table 48 Latin America endometrial ablation market, by product, 2018 - 2030 (USD Million)
  • Table 49 Latin America endometrial ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 50 Brazil endometrial ablation market, by product, 2018 - 2030 (USD Million)
  • Table 51 Brazil endometrial ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 52 Mexico endometrial ablation market, by product, 2018 - 2030 (USD Million)
  • Table 53 Mexico endometrial ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 54 Argentina endometrial ablation market, by product, 2018 - 2030 (USD Million)
  • Table 55 Argentina endometrial ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 56 Middle East & Africa endometrial ablation market, by country, 2018 - 2030 (USD Million)
  • Table 57 Middle East & Africa endometrial ablation market, by product, 2018 - 2030 (USD Million)
  • Table 58 Middle East & Africa endometrial ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 59 South Africa endometrial ablation market, by product, 2018 - 2030 (USD Million)
  • Table 60 South Africa endometrial ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 61 Saudi Arabia endometrial ablation market, by product, 2018 - 2030 (USD Million)
  • Table 62 Saudi Arabia endometrial ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 63 UAE endometrial ablation market, by product, 2018 - 2030 (USD Million)
  • Table 64 UAE endometrial ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 65 Kuwait endometrial ablation market, by product, 2018 - 2030 (USD Million)
  • Table 66 Kuwait endometrial ablation market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Endometrial ablation market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement process
  • Fig. 4 Primary research pattern
  • Fig. 5 Endometrial ablation market snapshot, 2022 (USD Million)
  • Fig. 6 Segment snapshot, USD Million
  • Fig. 7 Competitive landscape snapshot
  • Fig. 8 Penetration & growth prospect mapping, by product
  • Fig. 9 Market driver analysis (Current & future impact)
  • Fig. 10 Market restraint analysis (Current & future impact)
  • Fig. 11 Endometrial ablation market, product outlook key takeaways (USD Million)
  • Fig. 12 Endometrial ablation market: Product movement analysis (USD Million), 2022 & 2030
  • Fig. 13 Cryoablation market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 14 Radiofrequency ablation market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 15 Hydrothermal ablation market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 16 Thermal balloon market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 17 Microwave energy market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Endometrial ablation market, end use outlook key takeaways (USD Million)
  • Fig. 20 Endometrial ablation market: End use movement analysis (USD Million), 2022 & 2030
  • Fig. 21 Hospitals market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Clinics market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Ambulatory centers market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Endometrial ablation market: Regional key takeaways (USD Million)
  • Fig. 25 Endometrial ablation market: Regional outlook, 2022 & 2030, USD Million
  • Fig. 26 North America endometrial ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 U.S. endometrial ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Canada endometrial ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Europe endometrial ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 UK endometrial ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Germany endometrial ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 France endometrial ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Spain endometrial ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Italy endometrial ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Sweden endometrial ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Norway endometrial ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Denmark endometrial ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Asia Pacific endometrial ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 China endometrial ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Japan endometrial ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 India endometrial ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 South Korea endometrial ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Australia endometrial ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Thailand endometrial ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Latin America endometrial ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Brazil endometrial ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Mexico endometrial ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Argentina endometrial ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Middle East and Africa endometrial ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 South Africa endometrial ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Saudi Arabia endometrial ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 UAE endometrial ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Kuwait endometrial ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 List of key emerging company's/technology disruptors/innovators
目次
Product Code: GVR-4-68039-608-0

Endometrial Ablation Market Growth & Trends:

The global endometrial ablation market size is expected to reach USD 1.69 billion by 2030, expanding at a CAGR of 5.16% from 2023 to 2030, based on a new report by Grand View Research, Inc.. This growth can be attributed to the growing prevalence of gynecological disorders and public awareness about endometrial ablation procedures. According to the Endocrine Society, PCOS affects between 7% and 10% of all women of reproductive age and is the foremost cause of infertility, which will certainly contribute to the overall market growth. Furthermore, the increased emphasis on raising awareness of gynecological cancer and the increasing prevalence of adenomyosis in women, especially after the age of 50 years, will have a positive impact on endometrial ablation surgery worldwide.

As per the United Nations ESCAP, out of the total population, around 53.2% of the population aged 60 years and above were women, and around 61.2% of the population aged 80 years and more were women in 2020. Thus, the rise in the geriatric women population also contributes to the market growth. Despite these favorable growth environments, the potential complications connected with uterine ablation surgery, like uterine perforation, high fever, and shortness of breath, may slightly impede market dynamics. Moreover, it has become possible to destroy the endometrium in situ in a day-care procedure due to the availability of minimally invasive endometrial ablation procedures as an alternative to surgeries. This procedure is less risky and technically simple to perform.

According to the International Federation of Gynecology and Obstetrics (FIGO), Abnormal Uterine Bleeding (AUB) in the reproductive years has a significant global impact, with an incidence of around 3 to 30% among reproductive-aged women. Thereby expected to propel the growth of the overall market. The global market players are undertaking various initiatives, such as organizing social media campaigns and launching websites to raise awareness about women-associated diseases, such as the AUB. This strategy enables companies to increase their capabilities, improve their competencies, and expand their product portfolios. For instance, in August 2022, Minerva Surgical, Inc. launched a "Time to Talk" social media campaign and local event series. This initiative will help raise awareness about AUB worldwide. This initiative will increase the consumer base for endometrial ablation devices, driving revenue generation.

Endometrial Ablation Market Report Highlights:

  • In 2022, the radiofrequency ablation (RFA) product segment dominated the market owing to the increased demand for RFA devices for removal of endometrial layers
  • In 2022, the clinics segment dominated the market owing to the increased preference for clinics over hospitals to perform endometrial ablation procedures
  • North America held the largest share in 2022 owing to the rising cases of gynecological disorders, improvement in healthcare infrastructure, and a strong foundation of top industry players to deliver cutting-edge endometrial ablation devices
  • Market players adopt various strategies to increase the reach of their products in the market and improve availability in diverse geographic areas

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. End-use
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline.
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database.
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for primary interviews in North America
      • 1.3.5.2. Data for primary interviews in Europe
      • 1.3.5.3. Data for primary interviews in Asia Pacific
      • 1.3.5.4. Data for primary interviews in Latin America
      • 1.3.5.5. Data for Primary interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. End-use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Endometrial Ablation Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising number of uterine problems
      • 3.2.1.2. Increasing preference towards minimally invasive surgical procedures
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Rising treatment costs
      • 3.2.2.2. Presence of alternative treatment options
  • 3.3. Endometrial Ablation Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Endometrial Ablation Market: Product Estimates & Trend Analysis

  • 4.1. Product Market Share, 2018 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Endometrial Ablation Market by Product Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2023 to 2030 for the following
    • 4.4.1. Cryoablation
      • 4.4.1.1. Cryoablation market estimates and forecast 2018 to 2030 (USD Million)
    • 4.4.2. Radiofrequency Ablation
      • 4.4.2.1. Radiofrequency ablation market estimates and forecast 2018 to 2030 (USD Million)
    • 4.4.3. Hydrothermal Ablation
      • 4.4.3.1. Hydrothermal ablation market estimates and forecast 2018 to 2030 (USD Million)
    • 4.4.4. Thermal Balloon
      • 4.4.4.1. Thermal balloon market estimates and forecast 2018 to 2030 (USD Million)
    • 4.4.5. Microwave Energy
      • 4.4.5.1. Microwave energy market estimates and forecast 2018 to 2030 (USD Million)
    • 4.4.6. Others
      • 4.4.6.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Endometrial Ablation Market: End-use Estimates & Trend Analysis

  • 5.1. End-use Market Share, 2018 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Endometrial Ablation Market by End-use Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2023 to 2030 for the following
    • 5.4.1. Hospitals
      • 5.4.1.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million)
    • 5.4.2. Clinics
      • 5.4.2.1. Clinics market estimates and forecast 2018 to 2030 (USD Million)
    • 5.4.3. Ambulatory Surgical Centers
      • 5.4.3.1. Ambulatory surgical centers market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Endometrial Ablation Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2018 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. Market Size, & Forecasts Trend Analysis, 2023 to 2030:
  • 6.5. North America
    • 6.5.1. U.S.
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Competitive Scenario
      • 6.5.1.3. Regulatory framework
      • 6.5.1.4. Reimbursement scenario
      • 6.5.1.5. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.2. Canada
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Competitive Scenario
      • 6.5.2.3. Regulatory framework
      • 6.5.2.4. Reimbursement scenario
      • 6.5.2.5. Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.6. Europe
    • 6.6.1. UK
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Competitive Scenario
      • 6.6.1.3. Regulatory framework
      • 6.6.1.4. Reimbursement scenario
      • 6.6.1.5. UK market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.6.2. Germany
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Competitive Scenario
      • 6.6.2.3. Regulatory framework
      • 6.6.2.4. Reimbursement scenario
      • 6.6.2.5. Germany market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.6.3. France
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Competitive Scenario
      • 6.6.3.3. Regulatory framework
      • 6.6.3.4. Reimbursement scenario
      • 6.6.3.5. France market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.6.4. Italy
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Competitive Scenario
      • 6.6.4.3. Regulatory framework
      • 6.6.4.4. Reimbursement scenario
      • 6.6.4.5. Italy market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.6.5. Spain
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Competitive Scenario
      • 6.6.5.3. Regulatory framework
      • 6.6.5.4. Reimbursement scenario
      • 6.6.5.5. Spain market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.6.6. Norway
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Competitive Scenario
      • 6.6.6.3. Regulatory framework
      • 6.6.6.4. Reimbursement scenario
      • 6.6.6.5. Norway market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.6.7. Sweden
      • 6.6.7.1. Key country dynamics
      • 6.6.7.2. Competitive Scenario
      • 6.6.7.3. Regulatory framework
      • 6.6.7.4. Reimbursement scenario
      • 6.6.7.5. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.6.8. Denmark
      • 6.6.8.1. Key country dynamics
      • 6.6.8.2. Competitive Scenario
      • 6.6.8.3. Regulatory framework
      • 6.6.8.4. Reimbursement scenario
      • 6.6.8.5. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.7. Asia Pacific
    • 6.7.1. Japan
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Competitive Scenario
      • 6.7.1.3. Regulatory framework
      • 6.7.1.4. Reimbursement scenario
      • 6.7.1.5. Japan market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.7.2. China
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Competitive Scenario
      • 6.7.2.3. Regulatory framework
      • 6.7.2.4. Reimbursement scenario
      • 6.7.2.5. China market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.7.3. India
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Competitive Scenario
      • 6.7.3.3. Regulatory framework
      • 6.7.3.4. Reimbursement scenario
      • 6.7.3.5. India market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.7.4. Australia
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Competitive Scenario
      • 6.7.4.3. Regulatory framework
      • 6.7.4.4. Reimbursement scenario
      • 6.7.4.5. Australia market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.7.5. South Korea
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Competitive Scenario
      • 6.7.5.3. Regulatory framework
      • 6.7.5.4. Reimbursement scenario
      • 6.7.5.5. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.7.6. Thailand
      • 6.7.6.1. Key country dynamics
      • 6.7.6.2. Competitive Scenario
      • 6.7.6.3. Regulatory framework
      • 6.7.6.4. Reimbursement scenario
      • 6.7.6.5. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.8. Latin America
    • 6.8.1. Brazil
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Competitive Scenario
      • 6.8.1.3. Regulatory framework
      • 6.8.1.4. Reimbursement scenario
      • 6.8.1.5. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.8.2. Mexico
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Competitive Scenario
      • 6.8.2.3. Regulatory framework
      • 6.8.2.4. Reimbursement scenario
      • 6.8.2.5. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.8.3. Argentina
      • 6.8.3.1. Key country dynamics
      • 6.8.3.2. Competitive Scenario
      • 6.8.3.3. Regulatory framework
      • 6.8.3.4. Reimbursement scenario
      • 6.8.3.5. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.9. MEA
    • 6.9.1. South Africa
      • 6.9.1.1. Key country dynamics
      • 6.9.1.2. Competitive Scenario
      • 6.9.1.3. Regulatory framework
      • 6.9.1.4. Reimbursement scenario
      • 6.9.1.5. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.9.2. Saudi Arabia
      • 6.9.2.1. Key country dynamics
      • 6.9.2.2. Competitive Scenario
      • 6.9.2.3. Regulatory framework
      • 6.9.2.4. Reimbursement scenario
      • 6.9.2.5. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.9.3. UAE
      • 6.9.3.1. Key country dynamics
      • 6.9.3.2. Competitive Scenario
      • 6.9.3.3. Regulatory framework
      • 6.9.3.4. Reimbursement scenario
      • 6.9.3.5. UAE market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.9.4. Kuwait
      • 6.9.4.1. Key country dynamics
      • 6.9.4.2. Competitive Scenario
      • 6.9.4.3. Regulatory framework
      • 6.9.4.4. Reimbursement scenario
      • 6.9.4.5. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
    • 7.2.1. Innovators
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis, 2022
    • 7.3.4. Medtronic.
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. The Cooper Companies, Inc.
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. Boston Scientific Corporation
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. Johnson & Johnson Service Inc.
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Olympus Corporation
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. Richard Wolf GmbH.
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. AngioDynamics.
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. Hologic, Inc.
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Product benchmarking
      • 7.3.11.4. Strategic initiatives
    • 7.3.12. Minerva Surgical, Inc.
      • 7.3.12.1. Company overview
      • 7.3.12.2. Financial performance
      • 7.3.12.3. Product benchmarking
      • 7.3.12.4. Strategic initiatives